Sage Therapeutics announced its boards unanimous rejection of Biogens $469 million acquisition offer, stating the proposal ...
As winter’s chill settles in, it’s the perfect time to experiment with layering—and this season, it’s all about combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback